GALLI, Ubaldina
 Distribuzione geografica
Continente #
EU - Europa 2.114
NA - Nord America 2.073
AS - Asia 1.244
SA - Sud America 207
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.675
Nazione #
US - Stati Uniti d'America 2.008
IE - Irlanda 498
SG - Singapore 375
IT - Italia 369
DE - Germania 330
CN - Cina 291
SE - Svezia 285
HK - Hong Kong 191
UA - Ucraina 188
BR - Brasile 152
FI - Finlandia 114
VN - Vietnam 114
RU - Federazione Russa 111
IN - India 109
TR - Turchia 57
FR - Francia 54
GB - Regno Unito 52
CA - Canada 50
EE - Estonia 19
PL - Polonia 19
AR - Argentina 17
BD - Bangladesh 17
BE - Belgio 17
CZ - Repubblica Ceca 17
IR - Iran 17
ID - Indonesia 14
JP - Giappone 14
ZA - Sudafrica 14
KR - Corea 11
MX - Messico 11
LT - Lituania 10
VE - Venezuela 8
AT - Austria 7
ES - Italia 7
CO - Colombia 6
EC - Ecuador 6
IQ - Iraq 6
PE - Perù 5
PK - Pakistan 5
BJ - Benin 4
CL - Cile 4
NL - Olanda 4
PY - Paraguay 4
SA - Arabia Saudita 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
GR - Grecia 3
MA - Marocco 3
PH - Filippine 3
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
GA - Gabon 2
KE - Kenya 2
LB - Libano 2
PA - Panama 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MY - Malesia 1
NE - Niger 1
NO - Norvegia 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.675
Città #
Dublin 498
Jacksonville 360
Hong Kong 191
Dearborn 171
Beijing 134
Singapore 121
Chandler 119
Ann Arbor 109
Piemonte 109
Ashburn 97
Wilmington 86
Lawrence 63
Princeton 63
Moscow 53
Los Angeles 52
Munich 39
San Mateo 38
Andover 37
Ho Chi Minh City 33
Bremen 32
Buffalo 26
New York 26
Santa Clara 25
Toronto 24
Ankara 23
Hanoi 23
São Paulo 22
Kecioeren 20
Nanjing 20
Redondo Beach 20
Helsinki 19
Milan 19
Dallas 17
Brno 16
Brussels 15
Novara 15
Warsaw 15
Frankfurt am Main 14
Hefei 14
Turku 13
Houston 12
Strasbourg 12
Tokyo 12
Woodbridge 12
Formigine 11
Jinan 11
Johannesburg 11
Kocaeli 11
Leawood 11
Montreal 11
Seoul 11
Dong Ket 10
Nuremberg 10
Chicago 9
Fairfield 9
Kaunas 9
Monmouth Junction 9
Poplar 9
Turin 9
Brooklyn 8
Denver 8
Kunming 8
Varallo 8
Boardman 7
Chennai 7
Da Nang 7
Norwalk 7
Zanjan 7
Bexley 6
Boston 6
Calvisano 6
Düsseldorf 6
Guangzhou 6
Nanchang 6
Orem 6
Albano Laziale 5
Annapolis 5
Atlanta 5
Berlin 5
Falkenstein 5
Grignasco 5
Padua 5
Phoenix 5
Seattle 5
Stockholm 5
The Dalles 5
Tianjin 5
Belo Horizonte 4
Cambridge 4
Caracas 4
Castiglione D'adda 4
Chengdu 4
Cotonou 4
Guayaquil 4
Haiphong 4
Jakarta 4
Juneau 4
London 4
Manchester 4
Pavia 4
Totale 3.211
Nome #
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 160
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 145
Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 143
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 142
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 141
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 132
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 128
Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction 127
Combretabenzodiazepines: a novel class of antitubulin agents 122
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. 119
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 117
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. 116
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 113
Nicotinamide phosphoribosyltransferase (NAMPT) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH): interaction between moonlighting proteins as new molecular basis of cancer 106
The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors 106
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 102
Reaction Between (Z)-Arylchlorooximes and alpha-Isocyanoacetamides: a Procedure For The Synthesis of Aryl-alpha-Ketoamide amides 101
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 100
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 99
Characterization of NAD uptake in mammalian cells 99
Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases 96
Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2 91
“Characterization of nicotinamide phosphoribosyltransferase inhibitors as anticancer agents” 90
Aryl Azides as Forgotten Electrophiles in the Van Leusen Reaction: A Multicomponent Transformation Affording 4-Tosyl-1-arylimidazoles 90
Biochemical and structural analysis of a cytosolic sulfotransferase of the malaria vector Anopheles gambiae overexpressed in the reproductive tissues 89
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage 89
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 89
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 88
A fast route for the synthesis of tetrazolyl oximes by a novel multicomponent reaction between Z-chlorooximes, isocyanides and trimethylsilyl azide 88
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 87
Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase 86
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 86
A new furoxan NO-donor rabeprazole derivative and related compounds 86
Study of Anopheles gambiae 3-hydroxykynurenine transaminase activity and inhibition by LC-MS/MS method 84
Unsimmetrically substituted furoxan. Part 16. Reaction of benzenesulfonyl substituted furoxans with ethanol and ethanethiol in basic medium. 83
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry 83
Exploiting the Nucleophilicity of the Nitrogen Atom of Imidazoles: One-Pot Three-Component Synthesis of Imidazo-Pyrazines 82
Nicotinamide Phosphorybosyltransferase (NAMPT) Inhibitors are Novel Modulator of Cancer-Related Inflammation 78
A Successful Replacement of Phenols with Isocyanides in the Bargellini Reaction: Synthesis of 3-Carboxamido-Isobutyric Acids 78
null 77
CTLA-4 rs231775 and risk of acute renal graft rejection: an updated meta-analysis with trial sequential analysis 77
Gene polymorphisms and risk of acute renal graft rejection: a field synopsis of meta-analyses and genome-wide association studies 75
“Synthesis and in vitro evaluation of tetrasubstituted pyridines as potential PI3Ks inhibitors” 72
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 71
“Nicotinamide phosphoribosyl transferase (Nampt) inhibitors as antitumoral agents” 70
“Synthesis and biological evaluation of triazole analogues of FK866, a potent inhibitor of human Nicotinamide Phosphoribosyltransferase” 69
Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists? 68
Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds 66
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 65
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 65
"Progettazione e sintesi di derivati furossanici solubili come profarmaci dell'ossido di azoto" 65
“Antisecretory and Gastroprotective Activities of a Nitric Oxide (NO)-Releasing Derivative of the Proton Pump Inhibitor Rabeprazole” 65
“Discovery of a nanomolar inhibitor of NMPRTase by Click Chemistry” 65
“Identification of the first selective Sirt3 inhibitor”, 65
“Sirtuins, new potential targets for HIV-therapy” 63
“A New Furoxan NO-donor Rabeprazole Derivative and Related Compounds” 62
“Characterization of lipopeptide biosurfactants produced by Bacillus Licheniformis having anti-adhesion activity against pathogenic micro-organism”, 61
“Visfatin: new role as cytokine in tumour microenviroment” 61
“Water Soluble Furoxan Derivetives as NO Prodrugs” 60
Water Soluble Furoxan Derivatives as NO Prodrugs 59
Multicomponent reaction between (Z)-chloroximes, isocyanides and NH-heterocyclic rings 59
“Nicotinamide phosphoribosyltransferase (Nampt) inhibitors as anti-cancer agents in neuroblastoma” 54
“Synthesis and biological evaluation of analogues of FK866, a potent inhibitor of human NMPRTase, a crucial enzyme in the salvage pathway of NAD+ biosynthesis”, 54
α-Amino Acids as Synthons in the Ugi-5-Centers-4-Components Reaction: Chemistry and Applications 43
Synthesis and characterization of bis-triazolyl-pyridine derivatives as noncanonical dna-interacting compounds 41
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 39
An adamantane-based ligand as a novel chemical tool for thermosensory TRPM8 channel therapeutic modulation 19
Totale 5.771
Categoria #
all - tutte 32.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021307 0 0 0 0 0 30 71 10 80 30 70 16
2021/2022483 36 9 47 55 28 3 43 8 32 29 60 133
2022/20231.162 73 49 61 20 88 117 51 72 542 6 41 42
2023/2024320 33 24 43 18 54 0 67 6 4 0 19 52
2024/2025771 19 14 55 12 18 64 76 62 182 89 29 151
2025/20261.213 125 89 192 415 281 111 0 0 0 0 0 0
Totale 5.771